GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLY) » Definitions » Momentum Rank

ANSLY (Ansell) Momentum Rank : 9 (As of Dec. 11, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Ansell Momentum Rank?

Ansell has the Momentum Rank of 9.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Competitive Comparison of Ansell's Momentum Rank

For the Medical Instruments & Supplies subindustry, Ansell's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ansell's Momentum Rank Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Ansell's Momentum Rank falls into.



Ansell Momentum Rank Related Terms

Thank you for viewing the detailed overview of Ansell's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Ansell Business Description

Traded in Other Exchanges
Address
678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.

Ansell Headlines

From GuruFocus

Half Year 2019 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

Australian Ansell Expanding Into Medical Supplies

By Holmes Osborne, CFA Holmes Osborne, CFA 02-15-2017

Half Year 2023 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

Half Year 2024 Ansell Ltd Earnings Presentation Transcript

By GuruFocus Research 09-13-2024

Full Year 2022 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

Half Year 2022 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

Ansell Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024

Full Year 2021 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

Full Year 2023 Ansell Ltd Trading Update Call Transcript

By GuruFocus Research 02-12-2024